The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection

Journal of Surgical Oncology

Volumn 109, Issue 6, 2014, Pages 542-547

  Gomez, D ^a   Wetherill, C ^a   Cheong, J ^a   Jones, L ^a   Marshall, E ^b   Damato, B ^b   Coupland, S E ^c   Ghaneh, P ^c   Poston, G J ^a   Malik, H Z ^a   Fenwick, S W ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

hepatectomy; hepatic resection; melanoma; metastases; ocular

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; LAPAROSCOPY; LIVER METASTASIS; LIVER RESECTION; MALE; METASTASIS RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; UVEA MELANOMA;

HEPATECTOMY; HEPATIC RESECTION; MELANOMA; METASTASES; OCULAR;

ADULT; AGED; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEPATECTOMY; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; POPULATION SURVEILLANCE; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; UVEAL NEOPLASMS;

EID: 84898797593     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23535     Document Type: Article

References (35)

1. Kujala E, Makitie T, Kivela T:, Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44: 4651-4659.
2. Gragoudas ES, Egan KM, Seddon JM, et al.: Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98: 383-389, discussion 390.
3. Kim IK, Lane AM, Gragoudas ES:, Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol 128: 871-875.
4. Augsburger JJ, Correa ZM, Shaikh AH:, Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009; 148: 119-127.
5. Eskelin S, Pyrhonen S, Summanen P, et al.: Screening for metastatic malignant melanoma of the uvea revisited. Cancer 1999; 85: 1151-1159.
6. Gombos DS, Van Quill KR, Uusitalo M, et al.: Geographic disparities in diagnostic screening for metastatic uveal melanoma. Ophthalmology 2004; 111: 2254-2258.
7. Eskelin S, Pyrhonen S, Hahka-Kemppinen M, et al.: A prognostic model and staging for metastatic uveal melanoma. Cancer 2003; 97: 465-475.
8. Diener-West M, Reynolds SM, Agugliaro DJ, et al.: Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 2004; 22: 2438-2444.
9. Kaiserman I, Amer R, Péer J:, Liver function tests in metastatic uveal melanoma. Am J Ophthalmol 2004; 137: 236-243.
10. Marshall E, Romaniuk C, Ghaneh P, et al.: MRI in the detection of hepatic metastases from high-risk uveal melanoma: A prospective study in 188 patients. Br J Ophthalmol 97: 159-163.
11. Eleuteri A, Damato B, Coupland SE, et al.: Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. IJBET 2012; 8: 18-35.
12. Damato B, Dopierala JA, Coupland SE:, Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 16: 6083-6092.
13. Damato B, Duke C, Coupland SE, et al.: Cytogenetics of uveal melanoma: A 7-year clinical experience. Ophthalmology 2007; 114: 1925-1931.
14. Couinaud C:, Anatomic principles of left and right regulated hepatectomy: Technics. J Chir (Paris) 1954; 70: 933-966.
15. Strasberg SM:, Nomenclature of hepatic anatomy and resections: A review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-355.
16. Clavien PA, Barkun J, de Oliveira ML, et al.: The Clavien-Dindo classification of surgical complications: Five-year experience. Ann Surg 2009; 250: 187-196.
17. Fournier GA, Albert DM, Arrigg CA, et al.: Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol 1984; 102: 80-82.
18. Gunduz K, Shields JA, Shields CL, et al.: Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am J Ophthalmol 1998; 125: 407-409.
19. Aoyama T, Mastrangelo MJ, Berd D, et al.: Protracted survival after resection of metastatic uveal melanoma. Cancer 2000; 89: 1561-1568.
20. Hsueh EC, Essner R, Foshag LJ, et al.: Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 2004; 100: 122-129.
21. Herman P, Machado MA, Montagnini AL, et al.: Selected patients with metastatic melanoma may benefit from liver resection. World J Surg 2007; 31: 171-174.
22. Caralt M, Marti J, Cortes J, et al.: Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci 18: 268-275.
23. Kodjikian L, Grange JD, Baldo S, et al.: Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2005; 243: 985-993.
24. Becker JC, Terheyden P, Kampgen E, et al.: Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 2002; 87: 840-845.
25. Cantore M, Fiorentini G, Aitini E, et al.: Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 1994; 80: 37-39.
26. Leyvraz S, Spataro V, Bauer J, et al.: Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997; 15: 2589-2595.
27. Bedikian AY, Legha SS, Mavligit G, et al.: Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995; 76: 1665-1670.
28. Frenkel S, Nir I, Hendler K, et al.: Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 2009; 93: 1042-1046.
29. Mariani P, Piperno-Neumann S, Servois V, et al.: Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol 2009; 35: 1192-1197.
30. Donoso LA, Berd D, Augsburger JJ, et al.: Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 1985; 103: 796-798.
31. Orcurto V, Denys A, Voelter V, et al.: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: Results from a pilot study. Melanoma Res 22: 63-69.
32. Servois V, Mariani P, Malhaire C, et al.: Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Eur J Surg Oncol 36: 189-194.
33. Patel M, Winston CB, Marr BP, et al.: Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma. Arch Ophthalmol 129: 1576-1582.
34. Strobel K, Bode B, Dummer R, et al.: Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 2009; 36: 1774-1782.
35. Eskelin S, Pyrhonen S, Summanen P, et al.: Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment. Ophthalmology 2000; 107: 1443-1449.